Lapsi Health, a healthtech startup based in the Netherlands and the USA, has officially received FDA Class IIA Clearance for Keikku, its newest medical innovation. Lapsi Health’s patented sound+AI platform is designed to create new opportunities in diagnostics, transforming how biometric data is acquired and analyzed.
Amsterdam, The Netherlands – Lapsi Health, a healthtech startup based in the Netherlands and the USA, has officially received FDA Class IIA Clearance ...
Satisfied Users & 
Approved Press Releases
